Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models

被引:0
|
作者
Jennifer I. Luebke
Christina M. Weaver
Anne B. Rocher
Alfredo Rodriguez
Johanna L. Crimins
Dara L. Dickstein
Susan L. Wearne
Patrick R. Hof
机构
[1] Boston University School of Medicine,M949, Department of Anatomy and Neurobiology
[2] Mount Sinai School of Medicine,Department of Neuroscience
[3] Mount Sinai School of Medicine,Computational Neurobiology and Imaging Center
[4] Franklin and Marshall College,Department of Mathematics and Computer Science
来源
关键词
Alzheimer’s disease; Amyloid; Computational modeling; Dendritic spine; Tau; Whole-cell patch-clamp;
D O I
暂无
中图分类号
学科分类号
摘要
In neurodegenerative disorders, such as Alzheimer’s disease, neuronal dendrites and dendritic spines undergo significant pathological changes. Because of the determinant role of these highly dynamic structures in signaling by individual neurons and ultimately in the functionality of neuronal networks that mediate cognitive functions, a detailed understanding of these changes is of paramount importance. Mutant murine models, such as the Tg2576 APP mutant mouse and the rTg4510 tau mutant mouse have been developed to provide insight into pathogenesis involving the abnormal production and aggregation of amyloid and tau proteins, because of the key role that these proteins play in neurodegenerative disease. This review showcases the multidimensional approach taken by our collaborative group to increase understanding of pathological mechanisms in neurodegenerative disease using these mouse models. This approach includes analyses of empirical 3D morphological and electrophysiological data acquired from frontal cortical pyramidal neurons using confocal laser scanning microscopy and whole-cell patch-clamp recording techniques, combined with computational modeling methodologies. These collaborative studies are designed to shed insight on the repercussions of dystrophic changes in neocortical neurons, define the cellular phenotype of differential neuronal vulnerability in relevant models of neurodegenerative disease, and provide a basis upon which to develop meaningful therapeutic strategies aimed at preventing, reversing, or compensating for neurodegenerative changes in dementia.
引用
收藏
页码:181 / 199
页数:18
相关论文
共 50 条
  • [1] Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models
    Luebke, Jennifer I.
    Weaver, Christina M.
    Rocher, Anne B.
    Rodriguez, Alfredo
    Crimins, Johanna L.
    Dickstein, Dara L.
    Wearne, Susan L.
    Hof, Patrick R.
    BRAIN STRUCTURE & FUNCTION, 2010, 214 (2-3): : 181 - 199
  • [2] Neuroendocrinology of neurodegenerative diseases - Insights from transgenic mouse models
    de Aguilar, JLG
    René, F
    Dupuis, L
    Loeffler, JP
    NEUROENDOCRINOLOGY, 2003, 78 (05) : 244 - 252
  • [3] Dendritic size of pyramidal neurons differs among mouse cortical regions
    Benavides-Piccione, Ruth
    Hamzei-Sichani, Farid
    Ballesteros-Yanez, Inmaculada
    DeFelipe, Javier
    Yuste, Rafael
    CEREBRAL CORTEX, 2006, 16 (07) : 990 - 1001
  • [4] Neurodegenerative tauopathies: Human disease and transgenic mouse models
    Lee, VMY
    Trojanowski, JQ
    NEURON, 1999, 24 (03) : 507 - 510
  • [5] Issues in establishing transgenic mouse models of neurodegenerative disease
    Games, D
    Barbour, R
    Grajeda, H
    Guido, T
    Johnson-Wood, K
    Khan, K
    Soriano, F
    Seubert, P
    Schenk, D
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 441 - 441
  • [7] Insights into cancer from transgenic mouse models
    Macleod, KF
    Jacks, T
    JOURNAL OF PATHOLOGY, 1999, 187 (01): : 43 - 60
  • [8] Neurodegenerative diseases:: Insights from Drosophila and mouse models
    Botas, J
    NEUROSCIENCES IN THE POSTGENOMIC ERA, 2003, : 85 - 103
  • [9] Transgenic mouse models of neurodegenerative disease caused by CAG/polyglutamine expansions
    Bates, GP
    Davies, SW
    MOLECULAR MEDICINE TODAY, 1997, 3 (11): : 508 - 515
  • [10] Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development.
    Jankowsky J.L.
    Savonenko A.
    Schilling G.
    Wang J.
    Xu G.
    Borchelt D.R.
    Current Neurology and Neuroscience Reports, 2002, 2 (5) : 457 - 464